HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs

References

• Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15:678
   PubMed Web of Science ®Google Scholar
• Yang QC, Zeng BF, Dong Y, Shi ZM, Jiang ZM, Huang J. Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome. Jpn J Clin Oncol 2007; 37:127 - 134
   PubMed Web of Science ®Google Scholar
• Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, et al. Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients. Clinical Cancer Research 2004; 10:8554 - 8560
   PubMed Web of Science ®Google Scholar
• Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, Ko S, et al. Prognostic significance of HIF-1alpha overexpression in human pancreatic cancer. Anticancer Res 2003; 23:4721 - 4727
   PubMed Web of Science ®Google Scholar
• Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002; 8:1831 - 1837
   PubMed Web of Science ®Google Scholar
• Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, et al. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol 2007; 38:1310 - 1320
   PubMed Web of Science ®Google Scholar
• Winter SC, Shah KA, Han C, Campo L, Turley H, Leek R, et al. The relation between hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer 2006; 107:757 - 766
   PubMed Web of Science ®Google Scholar
• Mizokami K, Kakeji Y, Oda S, Maehara Y. Relationship of hypoxia-inducible factor 1alpha and p21WAF1/CIP1 expression to cell apoptosis and clinical outcome in patients with gastric cancer. World J Surg Oncol 2006; 4:94
   PubMedGoogle Scholar
• Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000; 60:4693 - 4696
   PubMed Web of Science ®Google Scholar
• Theodoropoulos VE, Lazaris A, Sofras F, Gerzelis I, Tsoukala V, Ghikonti I, et al. Hypoxia-inducible factor 1alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 2004; 46:200 - 208
   PubMed Web of Science ®Google Scholar
• Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH, Semenza GL. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61:2911 - 2916
   PubMed Web of Science ®Google Scholar
• Unruh A, Ressel A, Mohamed HG, Johnson RS, Nadrowitz R, Richter E, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 2003; 22:3213 - 3220
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271 - 275
   PubMed Web of Science ®Google Scholar
• Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996; 93:10595 - 10599
   PubMed Web of Science ®Google Scholar
• Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T, Vogt PK. Phosphatidylinositol-3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 2001; 12:363 - 369
   PubMedGoogle Scholar
• Fandrey J, Gorr TA, Gassmann M. Regulating cellular oxygen sensing by hydroxylation. Cardiovasc Res 2006; 71:642 - 651
   PubMed Web of Science ®Google Scholar
• Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30:393 - 402
   PubMed Web of Science ®Google Scholar
• Gorlach A, Bonello S. The cross-talk between NFkappaB and HIF-1: further evidence for a significant liaison. Biochem J 2008; 412:17 - 19
   PubMedGoogle Scholar
• van Uden P, Kenneth NS, Rocha S. Regulation of hypoxia-inducible factor-1alpha by NFkappaB. Biochem J 2008; 412:477 - 484
   PubMed Web of Science ®Google Scholar
• Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 2007; 27:755 - 761
   PubMed Web of Science ®Google Scholar
• Deudero JJ, Caramelo C, Castellanos MC, Neria F, Fernandez-Sanchez R, Calabia O, et al. Induction of hypoxia-inducible factor 1alpha gene expression by vascular endothelial growth factor. J Biol Chem 2008; 283:11435 - 11444
   PubMed Web of Science ®Google Scholar
• Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 1998; 17:5085 - 5094
   PubMed Web of Science ®Google Scholar
• Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 1999; 59:3915 - 3918
   PubMed Web of Science ®Google Scholar
• Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999; 94:1561 - 1567
   PubMed Web of Science ®Google Scholar
• Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol-3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60:1541 - 1545
   PubMed Web of Science ®Google Scholar
• Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 2001; 89:47 - 54
   PubMed Web of Science ®Google Scholar
• Spinella F, Rosano L, Di Castro V, Natali PG, Bagnato A. Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1alpha in ovarian carcinoma cells. J Biol Chem 2002; 277:27850 - 27855
   PubMed Web of Science ®Google Scholar
• Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21:3995 - 4004
   PubMed Web of Science ®Google Scholar
• Bardos JI, Chau NM, Ashcroft M. Growth factor-mediated induction of HDM2 positively regulates hypoxia-inducible factor 1alpha expression. Mol Cell Biol 2004; 24:2905 - 2914
   PubMed Web of Science ®Google Scholar
• Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 2003; 22:4082 - 4090
   PubMed Web of Science ®Google Scholar
• Blundell RA. The Biology of p21—Review Paper. American Journal of Biochemistry and Biotechnology 2006; 2:33 - 40
   Google Scholar
• Morris MR, Hughes DJ, Tian YM, Ricketts CJ, Lau KW, Gentle D, et al. Mutation Analysis of Hypoxia-inducible Factors HIF1A and HIF2A in Renal Cell Carcinoma. Anticancer Research 2009; 29:4337 - 4343
   PubMed Web of Science ®Google Scholar
• Bates S, Ryan KM, Phillips AC, Vousden KH. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 1998; 17:1691 - 1703
   PubMed Web of Science ®Google Scholar
• Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim Biophys Acta 2000; 1471:43 - 56
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Daido S, Yamamoto A, Kobayashi R, Yokoyama T, Aoki H, et al. Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J Biol Chem 2008; 283:388 - 397
   PubMed Web of Science ®Google Scholar
• Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1:639 - 649
   PubMed Web of Science ®Google Scholar
• Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805 - 816
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9:1149 - 1163
   PubMed Web of Science ®Google Scholar
• Costanzi-Strauss E, Strauss BE, Naviaux RK, Haas M. Restoration of growth arrest by p16INK4, p21WAF1, pRB and p53 is dependent on the integrity of the endogenous cell cycle control pathways in human glioblastoma cell lines. Exp Cell Res 1998; 238:51 - 62
   PubMed Web of Science ®Google Scholar
• Murakami H, Nurse P. DNA replication and damage checkpoints and meiotic cell cycle controls in the fission and budding yeasts. Biochem J 2000; 349:1 - 12
   PubMed Web of Science ®Google Scholar
• Kennett SB, Udvadia AJ, Horowitz JM. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res 1997; 25:3110 - 3117
   PubMed Web of Science ®Google Scholar
• Lee SJ, Ha MJ, Lee J, Nguyen P, Choi YH, Pirnia F, et al. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem 1998; 273:10618 - 10623
   PubMed Web of Science ®Google Scholar
• Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H, et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 1997; 389:187 - 190
   PubMed Web of Science ®Google Scholar
• Li JM, Datto MB, Shen X, Hu PP, Yu Y, Wang XF. Sp1, but not Sp3, functions to mediate promoter activation by TGFbeta through canonical Sp1 binding sites. Nucleic Acids Res 1998; 26:2449 - 2456
   PubMed Web of Science ®Google Scholar
• Prowse DM, Bolgan L, Molnar A, Dotto GP. Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. J Biol Chem 1997; 272:1308 - 1314
   PubMed Web of Science ®Google Scholar
• Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997; 272:22199 - 22206
   PubMed Web of Science ®Google Scholar
• Billon N, van Grunsven LA, Rudkin BB. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 1996; 13:2047 - 2054
   PubMed Web of Science ®Google Scholar
• Deniaud E, Baguet J, Chalard R, Blanquier B, Brinza L, Meunier J, et al. Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition. PLoS One 2009; 4:7035
   PubMed Web of Science ®Google Scholar
• Gervais JL, Seth P, Zhang H. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis. J Biol Chem 1998; 273:19207 - 19212
   PubMed Web of Science ®Google Scholar
• Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995; 82:405 - 414
   PubMed Web of Science ®Google Scholar
• Lacour S, Hammann A, Grazide S, Lagadic-Gossmann D, Athias A, Sergent O, et al. Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells. Cancer Res 2004; 64:3593 - 3598
   PubMed Web of Science ®Google Scholar
• Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, et al. A role for ceramide in driving cancer cell resistance to doxorubicin. Faseb J 2008; 22:2541 - 2551
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, Robey R, Bates S, Fojo T. Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. J Clin Invest 2000; 105:533 - 539
   PubMed Web of Science ®Google Scholar
• Carbonaro M, O'Brate A, Giannakakou P. Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression. J Cell Biol 2011; 192:83 - 99
   PubMed Web of Science ®Google Scholar
• Levine B, Yuan J. Autophagy in cell death: an innocent convict?. J Clin Invest 2005; 115:2679 - 2688
   PubMed Web of Science ®Google Scholar
• Tiwari M, Bajpai VK, Sahasrabuddhe AA, Kumar A, Sinha RA, Behari S, Godbole MM. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells. Carcinogenesis 2008; 29:600 - 609
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326 - 336
   PubMed Web of Science ®Google Scholar
• Schumm K, Rocha S, Caamano J, Perkins ND. Regulation of p53 tumour suppressor target gene expression by the p52 NFkappaB subunit. EMBO J 2006; 25:4820 - 4832
   PubMed Web of Science ®Google Scholar
• Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NFkappaB transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15 - 25
   PubMed Web of Science ®Google Scholar
• Kenneth NS, Mudie S, van Uden P, Rocha S. SWI/SNF regulates the cellular response to hypoxia. J Biol Chem 2009; 284:4123 - 4131
   PubMed Web of Science ®Google Scholar
• Culver C, Sundqvist A, Mudie S, Melvin A, Xirodimas D, Rocha S. Mechanism of Hypoxia-Induced NF{kappa}B. Mol Cell Biol 2010; 30:4901 - 4921
   PubMed Web of Science ®Google Scholar